In in vitro co-culture experiments, hp-iNSCtk efficiently killed D283 MB tumor cells (Fig 5G), suggesting in vivo potency of hp-iNSCtk therapy against a second molecularly distinct MB cell line. The gene discussed is HP; the disease is neoplasm.